Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dx Departure: US FDA's Diagnostics Chief Gutierrez Steps Down

Sep 28 2017

• By David Filmore

Related Content

Maisel Reassumes Acting FDA Device-Evaluation Chief Role As John Sheets Departs

May 31 2017

23andMe Opens Up FDA Pathway For DTC Genetic Predisposition Tests

Apr 06 2017

Diagnostics Reg Overhaul Floated In US House

Mar 21 2017

Radiology Devices Move To OIVD: More Cohesive Dx Reviews Ahead?

Feb 01 2010

FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans

May 17 2010

FDA Aims To Finalize Framework For Lab-Developed Tests In Near Term

Jun 21 2010

Under New Leadership, FDA Diagnostics Office To Tighten Its Control

Jul 27 2009

What's Next For LDTs? FDA May Be Eyeing A New Game Plan

Nov 25 2016

Related Companies

GRAIL Inc.

23andMe, Inc.

Additional Topics

United States Regulation Executive Changes In Vitro Diagnostics Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window